Jack R. Wands, MD, FAASLD
Jack R. Wands, MD, FAASLD
It is with profound sadness that we announce the passing of Jack R. Wands, MD, FAASLD, 80, Chief of the Division of Gastroenterology at the Warren Alpert Medical School of Brown University and Rhode Island Hospital/Lifespan. Jack was a leader in the field of Hepatology and among the most prolific investigators in the history of the medical school. His dominant scholarly accomplishments included improving our understanding of the molecular pathogenesis of chronic Hepatitis B and C, and dissecting pivotal intracellular signaling networks that govern the progression of alcohol-related liver disease to either cirrhosis or liver cancer. Those efforts led to pioneering research and the discovery of tumor-associated molecules that drive the invasive and metastatic spread of liver cancer cells. Importantly, the lessons learned were found highly relevant to many other malignancies, holding promise for novel diagnostic and therapeutic strategies for tumors that still lack effective treatment. Throughout his career, Jack was passionate about translating his important laboratory research discoveries to advance liver cancer diagnostics and therapeutics in human patients. In conjunction with his scholarly activities, Jack was a superb mentor who had an impressive impact on the successes and career trajectories of countless trainees. These ranged from undergraduate, graduate, and medical students to postdoctoral fellows and junior to mid-career faculty on virtually every continent. He is survived by his children, Greg and Raymie and his grandchildren Robby and Amanda.
2023 AASLD General Election Results
The AASLD general elections ran from Monday, September 18, 2023 to Friday, October 6th, 2023. The ballot included 1 Vacant Councilor-at-Large position, 2 Vacant Nominating Committee positions, and a bylaws amendment.
TLMdx Access
Please note to access TLMdX or the Mobile App you will use your registration # for your username and your last name for your password.
Nova Nomenclatura Esteatose Hepática
Não mais NAFLD! Em nossa língua Esteatose Hepática é o novo termo geral. E é criada a nova nomenclatura Esteatose Hepática Metabólica (MASLD).
Nouvelle Nomenclature NAFLD
Fini le NAFLD ! La stéatose hépatique est le terme général ; NAFLD est maintenant MAFLD.
GI Multi-Society Statement Regarding GLP-1 Agonists and Endoscopy
AASLD, ACG, AGA, ASGE and NASPGHAN recognize that the new class of medications known as glucagon-like peptide-1 (GLP-1) receptor...
Nueva Nomenclatura EHGNA
¡Ya no más EHGNA! En nuestra lengua Esteatosis Hepatica es el nuevo término general. Y se crea la nueva nomenclatura Esteatosis Hepática Metabólica (MASLD).
AASLD Foundation Funds $2 Million in Liver Research and Career Development Grants in 2023
Alexandria, VA – The American Association for the Study of Liver Diseases (AASLD) Foundation, the largest medical society...